Anna-Maria Hoffmann-Vold is the Head of the inflammatory and fibrotic rheumatic disease research area at the Oslo University Hospital and the Head of translational research, University Hospital Zurich. She is a consultant taking care of patients with systemic sclerosis (SSc) and interstitial lung disease (ILD) associated with any disease. She is the convenor of the ERS/EULAR guideline for connective tissue diseases (CTD) associated ILD (CTD-ILD) and the EULAR study group chair on the lung in rheumatic and musculoskeletal diseases.
Dr Hoffmann-Vold’s main expertise and interest is on clinical and translational research related to SSc and other CTDs with an emphasis on ILD, pulmonary arterial hypertension, development of management recommendations, conduction of clinical trials.